Potential Molecular Target Prediction and Docking Verification of Hua-Feng-Dan in Stroke Based on Network Pharmacology
Open Access
- 28 October 2020
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020, 1-12
- https://doi.org/10.1155/2020/8872593
Abstract
Potential Molecular Target Prediction and Docking Verification of Hua-Feng-Dan in Stroke Based on Network Pharmacology: Objective. Hua-Feng-Dan (HFD) is a Chinese medicine for stroke. This study is to predict and verify potential molecular targets and pathways of HFD against stroke using network pharmacology. Methods. The TCMSP database and TCMID were used to search for the active ingredients of HFD, and GeneCards and DrugBank databases were used to search for stroke-related target genes to construct the component-target-disease by Cytoscape 3.7.1, which was further filtered by MCODE to build a core network. The STRING database was used to obtain interrelationships by topology and to construct a protein-protein interaction network. GO and KEGG were carried out through DAVID Bioinformatics. Autodock 4.2 was used for molecular docking. BaseSpace was used to correlate target genes with the GEO database. Results. Based on OB30 and DL0.18, 42 active ingredients were extracted from HFD, and 107 associated targets were obtained. PPI network and Cytoscape analysis identified 22 key targets. GO analysis suggested 51 cellular biological processes, and KEGG suggested that 60 pathways were related to the antistroke mechanism of HFD, with p53, PI3K-Akt, and apoptosis signaling pathways being most important for HFD effects. Molecular docking verified interactions between the core target (CASP8, CASP9, MDM2, CYCS, RELA, and CCND1) and the active ingredients (beta-sitosterol, luteolin, baicalein, and wogonin). The identified gene targets were highly correlated with the GEO biosets, and the stroke-protection effects of Xuesaitong in the database were verified by identified targets. Conclusion. HFD could regulate the symptoms of stroke through signaling pathways with core targets. This work provided a bioinformatic method to clarify the antistroke mechanism of HFD, and the identified core targets could be valuable to evaluate the antistroke effects of traditional Chinese medicines.Keywords
Funding Information
- National Natural Science Foundation of China (81560592, GZS-2016(07))
This publication has 38 references indexed in Scilit:
- Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: Gene expression profiles in the kidneysInternational Journal of Molecular Medicine, 2015
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicinesJournal of Cheminformatics, 2014
- TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysisNucleic Acids Research, 2012
- Mice Lacking the β2 Adrenergic Receptor Have a Unique Genetic Profile before and after Focal Brain IschaemiaASN Neuro, 2012
- Genomic Analysis of Reactive AstrogliosisJournal of Neuroscience, 2012
- Role of cinnabar and realgar of WSHFD in protecting against LPS-induced neurotoxicityJournal of Ethnopharmacology, 2012
- Upregulated Signaling Pathways in Ruptured Human Saccular Intracranial Aneurysm Wall: An Emerging Regulative Role of Toll-Like Receptor Signaling and Nuclear Factor-κB, Hypoxia-Inducible Factor-1A, and ETS Transcription FactorsNeurosurgery, 2011
- Genome response to tissue plasminogen activator in experimental ischemic strokeBMC Genomics, 2010
- A secretory phospholipase A2-mediated neuroprotection and anti-apoptosisBMC Neuroscience, 2009
- Modulation of p53 Degradation via MDM2-Mediated Ubiquitylation and the Ubiquitin–Proteasome System during Reperfusion after Stroke: Role of Oxidative StressJournal of Cerebral Blood Flow & Metabolism, 2005